Social Activist Demands Lab Testing Of Ayurvedic Medicine Used For Joint Pains

Jammu: (UNI) A Jammu based social activist Sukesh C Khajuria has sought laboratory testing of Ayurvedic medicine, being used for treating the joint pains.

The social activist had expressed his apprehensions related to the Ayurvedic composition known as ‘Batnashak Batika”, which he claimed is increasingly being utilized for the treatment of joint pains, particularly in patients who have suffered from ‘Chikungunya’ in Jammu and Kashmir. He wrote to the drug authorities in J&K that ‘Batnashak Batika’ reportedly demonstrates swift efficacy in alleviating post-Chikungunya joint pains, contrary to the conventional understanding that Ayurvedic herbal medicines typically facilitate gradual healing and recovery.

Given the remarkable and expeditious healing attributed to this Ayurvedic medicine, I harbour reservations regarding its composition,” he added.

He requested the Drug controller Jammu and Kashmir to conduct a thorough chemical examination of the composition to determine whether any steroids or potentially harmful substances have been incorporated to expedite relief, posing potential health risks to consumers. Khajuria and urged the authorities for a comprehensive chemical examination of the Ayurvedic medicine at the drug laboratory and disseminate the findings to the general public for the collective benefit of society.

He said he had alerted the drug authorities of Jammu and Kashmir, Union Health Minister and other central and union territory officials about the dangers of sale of such drugs.

Related Posts

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

New Delhi — India’s top drug regulator has issued a nationwide alert over 90 fixed-dose combination (FDC) drugs being manufactured and sold without mandatory central approval, directing all state and…

India’s drug body flags 90 unapproved FDC medicines, states told to take action

The Central Drugs Standard Control Organisation (CDSCO), India’s top drug regulator, has identified at least 90 unapproved fixed-dose combination (FDC) medicines in circulation and asked states to move against those…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

Unapproved drops for dry eyes pose risks: Govt

Unapproved drops for dry eyes pose risks: Govt

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward